Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial

OBJECTIVE: To assess the safety and efficacy of epigallocatechin-3-gallate (EGCG) add-on to glatiramer acetate (GA) in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: We enrolled patients with RRMS (aged 18–60 years, Expanded Disability Status Scale [EDSS] score 0–6.5), receivi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neurol Neuroimmunol Neuroinflamm
Huvudupphovsmän: Bellmann-Strobl, Judith, Paul, Friedemann, Wuerfel, Jens, Dörr, Jan, Infante-Duarte, Carmen, Heidrich, Elmira, Körtgen, Benedict, Brandt, Alexander, Pfüller, Caspar, Radbruch, Helena, Rust, Rebekka, Siffrin, Volker, Aktas, Orhan, Heesen, Christoph, Faiss, Jürgen, Hoffmann, Frank, Lorenz, Mario, Zimmermann, Benno, Groppa, Sergiu, Wernecke, Klaus-Dieter, Zipp, Frauke
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8054966/
https://ncbi.nlm.nih.gov/pubmed/33762428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000981
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk